Rab Prinjha

Directeur/Bestuurslid bij Padlock Therapeutics, Inc.

Health Technology

Consumer Services

Actieve functies van Rab Prinjha

Bedrijven	Functie	Begin	Einde
Padlock Therapeutics, Inc. Padlock Therapeutics, Inc. BiotechnologyHealth Technology Padlock Therapeutics, Inc. develops medicines targeting protein-arginine deiminases. It develops drugs that block the protein-arginine deiminase (PAD) enzymes. The firm leverages the breakthrough science on the role of protein citrullination in disease to develop drugs targeting protein-arginine deiminase (PAD) enzymes. The company was founded by Paul Thompson, Kerri Mowen, Todd A. Huffman and Michael Gilman in January 2014 and is headquartered in Cambridge, MA.	Directeur/Bestuurslid	-	-

Bedrijven	Functie	Begin	Einde
GSK PLC	Corporate Officer/Principal	-	-

University College London

Doctorate Degree

Internationaal

Verenigd Koninkrijk	3
Verenigde Staten	2

Operationeel

Director/Board Member	1
Doctorate Degree	1
Corporate Officer/Principal	1

Sectoraal

Health Technology	3
Consumer Services	2

Beklede functies

Actief

Inactief

Beursgenoteerde bedrijven

Bedrijven in privébezit

Beursgenoteerde bedrijven	1
GSK PLC	Health Technology

Bedrijven in privébezit	1
Padlock Therapeutics, Inc. Padlock Therapeutics, Inc. BiotechnologyHealth Technology Padlock Therapeutics, Inc. develops medicines targeting protein-arginine deiminases. It develops drugs that block the protein-arginine deiminase (PAD) enzymes. The firm leverages the breakthrough science on the role of protein citrullination in disease to develop drugs targeting protein-arginine deiminase (PAD) enzymes. The company was founded by Paul Thompson, Kerri Mowen, Todd A. Huffman and Michael Gilman in January 2014 and is headquartered in Cambridge, MA.	Health Technology

Bedrijven in privébezit

Health Technology